← Back to Search

Behavioural Intervention

SinuSonic Device for Eustachian Tube Dysfunction and Facial Pain

N/A
Recruiting
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults 18 years or older with no symptoms of URI, ETD or other ENT conditions
Adults 18 years or older who complain of facial pain or pressure, ≥3 months of symptoms duration (can be intermittent), Pain/pressure VAS score ≥ 5
Must not have
Sinonasal or ear surgery within last 3 months (including balloon ET dilation), Indwelling ear tubes, Tympanic membrane perforation, Hx of cholesteatoma, mastoidectomy, tympanoplasty, or ossicular chain reconstruction, Patulous ET, Hx of Meniere's disease, Moderate or severe nasal valve collapse, Grade 3-4 polyps, Upper respiratory illness within last 2 weeks, Topical decongestant use in last week, Current nasal crusting or ulceration on rhinoscopy, History of severe nose bleeding within last 3 months, Known pregnancy, Allergic sensitivity to silicone or any other component of device, Inability to read and understand English, Inability to perform treatment due to underlying medical condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 to 4 weeks
Awards & highlights

Summary

This trial tests the SinuSonic device, which uses sound and gentle pressure with normal breathing. It targets adults with eustachian tube dysfunction or facial pain/pressure. The device may help by increasing Nitric Oxide in the nose, which relaxes blood vessels and balances air pressure in the ear and sinuses.

Who is the study for?
This trial is for adults over 18 with facial pain or pressure for at least 3 months, or diagnosed Eustachian Tube Dysfunction (ETD) by an ENT specialist, with symptoms like ear pressure and muffled hearing. It's not for those who've had recent ear surgery, have certain ear conditions, severe nasal issues, a cold in the last two weeks, used nasal decongestants recently, are pregnant or can't understand English.
What is being tested?
The SinuSonic device is being tested to see if it helps adults with ETD or facial pain. The device combines sound and breathing techniques to potentially increase Nitric Oxide in the nose which might help balance gas pressures in the ears and sinuses.
What are the potential side effects?
Since this study involves a non-invasive device that uses acoustic vibration and oscillating expiratory pressure through normal breathing techniques, side effects may be minimal but could include discomfort from using the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older and do not have symptoms of upper respiratory or ear, nose, throat conditions.
Select...
I am an adult with facial pain or pressure for 3 months or more, and my pain level is at least 5 out of 10.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
Criterion: You had surgery in the nose or ear within the last 3 months, have certain ear conditions, severe nasal issues, or other medical conditions, or are pregnant or allergic to certain materials.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 to 4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 to 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Symptoms severity according to a Pain/pressure Visual Analogue Scale
Symptoms severity according to an ETD Visual Analogue Scale
Secondary outcome measures
McGill Pain Questionnaire - Short Form
Mean Change in Overall ETDQ-7 Score
Worst Pain Using the Modified Brief Pain Inventory - Short Form (m-BPI-sf)

Trial Design

1Treatment groups
Experimental Treatment
Group I: SinuSonic DeviceExperimental Treatment1 Intervention
Aim 1: SinuSonic device used once a day over a 2 day period. Aim 2: SinuSonic device used twice daily for 3 minutes in the home setting for 6 weeks. Aim 3: SinuSonic device used twice daily for 3 minutes in the home setting for 4 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SinuSonic Device
2019
N/A
~140

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor
960 Previous Clinical Trials
7,399,490 Total Patients Enrolled

Media Library

SinuSonic Device (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04404036 — N/A
Eustachian Tube Dysfunction Research Study Groups: SinuSonic Device
Eustachian Tube Dysfunction Clinical Trial 2023: SinuSonic Device Highlights & Side Effects. Trial Name: NCT04404036 — N/A
SinuSonic Device (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04404036 — N/A
~11 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top